| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |